Reply to Liao et al.: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World Analysis

Am J Respir Crit Care Med. 2022 Sep 1;206(5):647-648. doi: 10.1164/rccm.202205-0979LE.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antibody Formation
  • Asthma* / drug therapy
  • Biological Therapy
  • COVID-19 Vaccines / therapeutic use
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Vaccines, Synthetic
  • mRNA Vaccines

Substances

  • COVID-19 Vaccines
  • Vaccines, Synthetic
  • mRNA Vaccines